Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer [Phase 1]
Phase 1 trial evaluating the combination of lonafarnib, trastuzumab, and paclitaxel in HER2-overexpressing stage IIIB/IIIC or stage IV breas…
-
CLINICAL_TRIALS trial_result · 2012-09-11Clinical Trial Update: Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast Cancer [Phase 2]
A Phase 2 trial evaluating endocrine therapy plus OSI-906, with or without erlotinib, for hormone-sensitive metastatic breast cancer was ter…
-
CLINICAL_TRIALS trial_result · 2012-09-10Clinical Trial Update: Effect of a Low-Calorie Diet and/or Exercise Program on Risk Factors for Developing Breast Cancer in Overweight or Obese Postmenopausal Women [NA]
This document reports the completion of a clinical trial evaluating whether a low-calorie diet and/or an exercise program influence risk fac…
-
CLINICAL_TRIALS trial_result · 2012-09-10Clinical Trial Update: Comparison of Diagnostic Performance of an Algorithm and a High Definition Classical Iterative Algorithm Positron Emission Tomography (PET) to 18Fluoro-deoxy-glucose (18FDG) in the Evaluation of Axillary Lymph Node Invasion of Breast Tumors
This trial compared the diagnostic performance of a high-definition iterative PET algorithm to an alternative PET method against 18F-FDG in …
-
CLINICAL_TRIALS trial_result · 2012-09-10Clinical Trial Update: Family Quality of Life Among Families With a Member Who is a Cancer Patient
A completed ClinicalTrials.gov study from Vanderbilt-Ingram Cancer Center assessing family quality of life in households with a member who h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: Study to Investigate Adherence of Patients to Clodronate (Bonefos) Treatment
This completed clinical trial evaluated how well patients adhered to clodronate (Bonefos) therapy across several indications including breas…
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment [Phase 3]
Phase 3 trial update comparing Arimidex (anastrozole) and tamoxifen in premenopausal women with breast cancer under anti-hormonal treatment;…
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies [Phase 1]
Phase 1 safety study of a liposomal docetaxel formulation in patients with solid tumors who have failed prior therapy has been completed, ev…
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Healing Touch in Treating Fatigue in Women Undergoing Radiation Therapy for Breast Cancer [NA]
Completed clinical trial evaluating Healing Touch to treat fatigue in women undergoing radiation therapy for breast cancer; results were pos…
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Imaging HSP90 Inhibitor AUY922 on VEGF-89ZR-bevacizumab Positron Emission Tomography (PET)
Clinical trial update reporting completion of an imaging study using AUY922, an HSP90 inhibitor, with VEGF-89Zr-bevacizumab PET in breast ca…
-
CLINICAL_TRIALS trial_result · 2012-09-05Clinical Trial Update: Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery [Phase 2]
Phase 2 clinical trial evaluating erlotinib for breast cancer that can be removed by surgery has completed; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-08-31Clinical Trial Update: Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole [Phase 3]
Phase 3 results from the BOLERO-2 trial show that adding everolimus to exemestane improved progression-free survival in postmenopausal women…
-
CLINICAL_TRIALS trial_result · 2012-08-30Clinical Trial Update: Efficacy of RAD001 in Breast Cancer Patients With Bone Metastases [Phase 2]
Phase 2 trial evaluating the efficacy of everolimus (RAD001) in breast cancer patients with bone metastases. The update indicates a Phase 2 …
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast Cancer [Phase 2]
Phase 2 trial evaluating letrozole in combination with lapatinib as neoadjuvant therapy for early breast cancer; results were posted in 2012…
-
CLINICAL_TRIALS trial_result · 2012-08-28Clinical Trial Update: Safety and Efficacy of ALC in Breast Cancer in Subjects With Fatigue [Phase 2]
A Phase 2 trial evaluating ALC for breast cancer with fatigue was terminated.
-
CLINICAL_TRIALS trial_result · 2012-08-27Clinical Trial Update: Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer [Phase 2]
Phase 2 trial evaluating primary chemotherapy regimens (docetaxel-capecitabine and doxorubicin-cyclophosphamide) in breast cancer has comple…
-
CLINICAL_TRIALS trial_result · 2012-08-24Clinical Trial Update: Efficacy and Safety Study of LEP-ETU to Treat Metastatic Breast Cancer [Phase 2]
The completed Phase 2 trial reports on the efficacy and safety of LEP-ETU for metastatic breast cancer, sponsored by INSYS Therapeutics.
-
CLINICAL_TRIALS research · 2012-08-24Clinical Trial Update: Effect of Upper Limb Posture on Limb Volume as Expressed in Circumference Measurement in Healthy Women and in Women With Breast Cancer Related Lymphedema
This clinical trial assesses how upper limb posture influences limb volume measurements (circumference) in healthy women and in women with b…
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer [Phase 2]
A Phase 2 pilot study evaluating docetaxel with bevacizumab, with or without trastuzumab, as first-line therapy for metastatic breast cancer…
-
CLINICAL_TRIALS research · 2012-08-23Clinical Trial Update: Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating efficacy and safety of trastuzumab- and paclitaxel-based regimens for HER2-positive breast cancer.
-
CLINICAL_TRIALS trial_result · 2012-08-22Clinical Trial Update: Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug [Phase 2]
Phase 2 study using [F-18]RGD-K5 PET to monitor response to an anti-angiogenic cancer therapy has completed, with enrollment spanning metast…
-
CLINICAL_TRIALS trial_result · 2012-08-21Clinical Trial Update: Dose Dense Carboplatin, Taxotere and Herceptin As Primary Systemic Therapy in Breast Cancer [Phase 2]
This Phase 2 trial assesses a dose-dense regimen of carboplatin, docetaxel, and trastuzumab as initial systemic therapy for breast cancer.
-
CLINICAL_TRIALS research · 2012-08-20Clinical Trial Update: Detection of Benign and Malignant Thyroid and Breast Tumors by Fourier Transform Infrared Spectrometry
This clinical trial investigates using Fourier Transform Infrared Spectrometry to differentiate benign from malignant thyroid and breast tum…
-
CLINICAL_TRIALS trial_result · 2012-08-17Clinical Trial Update: Study to Assess Effect of 8 Wks of Duloxetine Therapy on Breast Cancer Patients With Aromatase-Inhibitor Associated Pain [NA]
This clinical trial update reports completion and results posting for an 8-week duloxetine therapy study in breast cancer patients experienc…
-
CLINICAL_TRIALS trial_result · 2012-08-16Clinical Trial Update: Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer [Phase 2]
Phase 2 trial evaluating the anti-tumor activity and tolerability of faslodex alone or in combination with arimidex in postmenopausal women …